About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.Stay Connected
My Profile
I am an authority on regulatory aspects of communications and medical products, with particular emphasis on pre-approval communications; strategist to help pharma and biotech companies prepare best case for advisory committee approval; and counselor in issues and crisis management. I am a frequent speaker on various aspects of same - drug development, promotion, reimbursement and new media in a highly regulated environment. Author of books, newspaper and magazine pieces related to drug marketing and promotion as well as HIV specialty pieces. And of course... blogger!About This Blog
Eye on FDA is published by Mark Senak of FleishmanHillard’s New York office. The thoughts and ideas in this blog and postings are strictly my own and are not screened by my employer. Everything posted on this blog is my personal opinion and does not necessarily represent the views of FleishmanHillard or its clients.
Posts by Date
April 2024 M T W T F S S 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 Twitter List
Legislative Tracking Tools
Category Archives: Business/Industry News
BMS Moves to Acquire ImClone
Ok, this is a few days late, but like I said, I was really busy this week. At any rate, here is the complete reprint of the press release from BMS. Bristol-Myers Squibb Proposes to Acquire ImClone Systems for $60.00 … Continue reading
Posted in Business/Industry News
Comments Off on BMS Moves to Acquire ImClone
Genentech Forms Special Committee of Independent Directors to Review Roche Proposal
I’ve decided to add a new category for Business/Industry News. In these cases, the posting will be a re-print of press releases affecting the industry that I find of high interest. This one is from Genentech on the Roche offer. … Continue reading
Posted in Business/Industry News
Comments Off on Genentech Forms Special Committee of Independent Directors to Review Roche Proposal